Donated placenta graft shows promise for chronic wounds
NCT ID NCT07041177
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a wound covering made from donated human placental tissue, called NeoThelium FT, in 10 adults with chronic open wounds that had not healed for at least 4 weeks. The goal was to see if the graft could help close the wound completely. Researchers measured wound closure and how long it stayed closed. Because the study is small and had no control group, the results are preliminary.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NeoThelium FT (a dehydrated wound covering made from donated human placental tissue)
- What this could lead to
- If successful, this could offer a new option to help close chronic open wounds that have not healed with standard care.
- What could go wrong
- This is a very small study with only 10 participants and no comparison group, so results may not apply to everyone. The product is still experimental.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN WOUND are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MedCentris of Hammond
Hammond, Louisiana, 70403, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.